Satasairaala on Porissa Tiilimäen kaupunginosassa toimiva maakunnallinen keskussairaala, jonka omistaa Satakunnan sairaanhoitopiirin kuntayhtymä. Sen toiminta-alue kattaa koko Satakunnan maakunnan.
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
The Hospital District of Satakunta
5
Turku University Hospital
5
Medicortex Finland Oy
2
Tampere University Hospital
2
University of Helsinki
2
University of Turku
2
CeloNova BioSciences, Inc.
1
Kuopio University Hospital
1
North Karelia Central Hospital
1
OrbusNeich
1
Oulu University Hospital
1
Clinical Trials at Satakunta Central Hospital
During the past decade, Satakunta Central Hospital conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Study of Vascular Healing With the Combo Stent Versus the Everolimus Eluting Stent in ACS Patients by Means of OCT
2011-10-01
2014-01-01
Completed
60
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Satakunta Central Hospital" #1 sponsor was "The Hospital District of Satakunta" with 5 trials, followed by "Turku University Hospital" with 5 trials
sponsored, "Medicortex Finland Oy" with 2 trials sponsored, "Tampere University Hospital" with 2 trials sponsored and "University of Helsinki"
with 2 trials sponsored. Other sponsors include 4 different institutions and
companies that sponsored additional 13 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Satakunta Central Hospital"
#1 collaborator was "Satakunta Central Hospital" with 6 trials as a collaborator, "Central Finland Hospital District" with 3 trials as a collaborator, "Helsinki University Central Hospital" with 3 trials as a collaborator, "Tampere University Hospital" with 3 trials as a collaborator and "Jyväskylä Central Hospital" with 2 trials as a collaborator. Other collaborators include 28 different institutions and companies that were
collaborators in the rest 35 trials.
Clinical Trials Conditions at Satakunta Central Hospital
According to Clinical.Site data, the most researched conditions in "Satakunta Central Hospital" are
"Acute Coronary Syndrome" (3 trials), "Coronary Artery Disease" (3 trials), "Atrial Fibrillation" (2 trials), "Prostate Cancer" (2 trials) and "Acute Coronary Syndrome (ACS)" (1 trials). Many other conditions were trialed in "Satakunta Central Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Satakunta Central Hospital
Most popular intervention types in "Satakunta Central Hospital" are "Device" (7 trials), "Procedure" (5 trials), "Drug" (4 trials), "Diagnostic Test" (3 trials) and "Other" (3 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "Sample collection" (2 trials), "A highly hydrolyzed formula" (1 trials), "A regular cow's milk based formula" (1 trials) and "A shared decision making" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Satakunta Central Hospital
The vast majority of trials in "Satakunta Central Hospital" are
22 trials for "All" genders and 3 trials for "Male" genders.
Clinical Trials Status at Satakunta Central Hospital
Currently, there are NaN active trials in "Satakunta Central Hospital".
undefined are not yet recruiting,
6 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 12 completed trials in Satakunta Central Hospital,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Satakunta Central Hospital, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 13 trials that are defined as “Not Applicable".